Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Activation in transformed cells of normal stem cells' self-renewal pathways might contribute to the survival life cycle of cancer stem cells and promote tumor progression. The BMI-1 oncogene-driven gene expression pathway is essential for the self-renewal of hematopoietic and neural stem cells. We applied a mouse/human comparative translational genomics approach to identify an 11-gene signature that consistently displays a stem cell-resembling expression profile in distant metastatic lesions as revealed by the analysis of metastases and primary tumors from a transgenic mouse model of prostate cancer and cancer patients. To further validate these results, we examined the prognostic power of the 11-gene signature in several independent therapy-outcome sets of clinical samples obtained from 1,153 cancer patients diagnosed with 11 different types of cancer, including 5 epithelial malignancies (prostate, breast, lung, ovarian, and bladder cancers) and 5 nonepithelial malignancies (lymphoma, mesothelioma, medulloblastoma, glioma, and acute myeloid leukemia). Kaplan-Meier analysis demonstrated that a stem cell-like expression profile of the 11-gene signature in primary tumors is a consistent powerful predictor of a short interval to disease recurrence, distant metastasis, and death after therapy in cancer patients diagnosed with 11 distinct types of cancer. These data suggest the presence of a conserved BMI-1-driven pathway, which is similarly engaged in both normal stem cells and a highly malignant subset of human cancers diagnosed in a wide range of organs and uniformly exhibiting a marked propensity toward metastatic dissemination as well as a high probability of unfavorable therapy outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated expression of this signature is associated with cancer development and chemotherapy resistance in different types of cancer, including hematological malignancies.11”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 4×
“We therefore sought to investigate whether measurements of expression of the 11-gene MTTS/PNS signature would be informative in the prediction of the patients’ prognosis in a group of 97 young women diagnosed with sporadic lymph node– negative early-stage breast cancer who were analyzed in a recent expression profilin…”
BackgroundMethodInfluentialA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Gene expression correlates of clinical prostate cancer behavior
Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00030-2 · Cited by 2,512
Systematic determination of genetic network architecture
Tavazoie, S., Hughes, J. D., Campbell, M. J., Cho, R. J., & Church, G. M. (1999) · Nature Genetics · doi:10.1038/10343 · Cited by 2,507 · cited 1×
“We calculated the significance of the overlap between the lists of stem cell–associated and prostate cancer–associated genes by using the hypergeometric distribution test (54).”
MethodA molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,817 · cited 1×
“Altered BMI-1 expression was implicated recently in several nonepithelial malignancies, such as B cell non-Hodgkin lymphoma (35) and pediatric brain tumors (36).”
BackgroundDelineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624 · cited 1×
“The concept of tumor stem cells implies that common genetic pathways might define critical stem cell–like functions in both normal and neoplastic stem cells (1, 5).”
BackgroundFusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J., & Alvarez-Buylla, A. (2003) · Nature · doi:10.1038/nature02069 · Cited by 1,617
Cell fusion is the principal source of bone-marrow-derived hepatocytes
Wang, X., Willenbring, H., Akkari, Y., Torimaru, Y., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., Olson, S., & Grompe, M. (2003) · Nature · doi:10.1038/nature01531 · Cited by 1,565
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466 · cited 1×
“Random concordant gene sets comprising approximately 200 transcripts were generated using a mouse transcriptome data set representing expression profiling data of approximately 12,000 transcripts across 38 normal tissues (55).”
MethodBmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452 · cited 3×
“The concept of tumor stem cells implies that common genetic pathways might define critical stem cell–like functions in both normal and neoplastic stem cells (1, 5).”
BackgroundBmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
Molofsky, A. V., Pardal, R., Iwashita, T., Park, I.-K., Clarke, M. F., & Morrison, S. J. (2003) · Nature · doi:10.1038/nature02060 · Cited by 1,310 · cited 2×
“Recent experiments established that the Bmi-1 gene is required for self-renewal of hematopoietic and neural stem cells (1–3) and identified BMI-1–regulated genes in neural stem cells that are presumably engaged in an execution of self-renewal programs in a state of both central nervous system (CNS) and peripheral nerv…”
BackgroundGene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,292
Transplanted bone marrow regenerates liver by cell fusion
Vassilopoulos, G., Wang, P.-R., & Russell, D. W. (2003) · Nature · doi:10.1038/nature01539 · Cited by 1,281
Aboody, K. S., Brown, A., Rainov, N. G., Bower, K. A., Liu, S., Yang, W., Small, J. E., Herrlinger, U., Ourednik, V., Black, P. M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12846 · Cited by 1,207 · cited 1×
“Accumulation of normal stem cells in experimental tumors in vivo has been demonstrated in several studies (45, 46).”
BackgroundNutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,058
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., & Chinnaiyan, A. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401994101 · Cited by 1,019 · cited 1×
“Perhaps inclusion of a relevant biological model in the signature discovery protocol was an essential component of the successful hit selection, since recent metaanalysis of cancer microarray data that was based solely on statistical approaches did not identify an outcome signature common to multiple cancer types (48).”
BackgroundUse of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia
Bullinger, L., Döhner, K., Bair, E., Fröhling, S., Schlenk, R. F., Tibshirani, R., Döhner, H., & Pollack, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031046 · Cited by 993
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., Chi, J.-T., Rijn, M. V. D., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 951 · cited 1×
“Most recently, the global gene expression profiling approach was successfully used to identify molecular signatures associated with activation of oncogenic pathways (28), targeted genetic manipulations (29), and cellular responses to physiological stimuli (30) and to build robust transcriptional identifiers that relia…”
BackgroundRosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 914
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 856
Metastasis genes: A progression puzzle
Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 798 · cited 1×
“Collectively, these data suggest an early involvement, in development of this transcriptionally defined subtype of human carcinomas, of a highly malignant combination of mutant alleles conferring the proclivity to metastasize (40) and/or an engagement of unique unconventional cellular targets such as stem cells and/or…”
BackgroundRhodes, D. R., Barrette, T. R., Rubin, M. A., Ghosh, D., & Chinnaiyan, A. M. (2002) · PubMed · Cited by 719
Metastatic prostate cancer in a transgenic mouse.
Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., & Greenberg, N. M. (1996) · PubMed · Cited by 599
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562 · cited 1×
“A recent study suggested a novel mechanism leading to development of frequent aneuploidy in human cancer due to aberrant expression of Mad2 protein, inappropriate activation of the spindle checkpoint, and, eventually, aneuploidy (50).”
BackgroundBmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas
Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., van Lohuizen, M., & Marino, S. (2004) · Nature · doi:10.1038/nature02385 · Cited by 543 · cited 1×
“Consistent with our findings, an increased BMI-1 expression in human medulloblastomas was demonstrated in a recent study (37).”
ResultLuo, J., Duggan, D. J., Chen, Y., Sauvageot, J., Ewing, C. M., Bittner, M. L., Trent, J. M., & Isaacs, W. B. (2001) · PubMed · Cited by 524
Latulippe, É., Satagopan, J. M., Smith, A., Scher, H. I., Scardino, P. T., Reuter, V. E., & Gerald, W. L. (2002) · PubMed · Cited by 518
Identifying distinct classes of bladder carcinoma using microarrays
Dyrskjøt, L., Thykjaer, T., Kruhøffer, M., Jensen, J. L., Marcussen, N., Hamilton-Dutoit, S., Wolf, H., & Ørntoft, T. F. (2003) · Nature Genetics · doi:10.1038/ng1061 · Cited by 501
Gene expression profiling predicts clinical outcome of prostate cancer
Glinsky, G. V., Glinskii, A. B., Stephenson, A. J., Hoffman, R. M., & Gerald, W. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20032 · Cited by 479 · cited 10×
“Detailed protocols for data analysis and documentation of the sensitivity, reproducibility, and other aspects of the quantitative statistical microarray analysis using Affymetrix technology have been reported previously (15, 16).”
BackgroundMethodResultInfluentialSelf-citationWeimann, J. M., Johansson, C. B., Trejo, A., & Blau, H. M. (2003) · Nature Cell Biology · doi:10.1038/ncb1053 · Cited by 451
Lu, K. H., Patterson, A. P., Wang, L., Marquez, R. T., Atkinson, E. N., Baggerly, K. A., Ramoth, L. R., Rosen, D. G., Liu, J., Hellstrom, I., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0409 · Cited by 440
Role of Hec1 in Spindle Checkpoint Signaling and Kinetochore Recruitment of Mad1/Mad2
Martin-Lluesma, S., Stucke, V. M., & Nigg, E. A. (2002) · Science · doi:10.1126/science.1075596 · Cited by 427 · cited 1×
“Both BUB1 and HEC1 proteins play a key role in the assembly of checkpoint proteins, being required for Mad2 recruitment to the kinetochores (51, 52); this suggests that aberrant BUB1 and HEC1 expression might contribute to and/or reflect the altered function of the mitotic checkpoint in metastatic cancer cells.”
BackgroundExpression profiling reveals hepsin overexpression in prostate cancer.
Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L. D., Humphrey, P. A., Catàlona, W. J., Watson, M. A., & Milbrandt, J. (2001) · PubMed · Cited by 425
A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 416 · cited 1×
“Most recently, the global gene expression profiling approach was successfully used to identify molecular signatures associated with activation of oncogenic pathways (28), targeted genetic manipulations (29), and cellular responses to physiological stimuli (30) and to build robust transcriptional identifiers that relia…”
BackgroundThe Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
Dimri, G. P., Martínez‐Guitarte, J., Jacobs, J. J. L., Keblusek, P., Itahana, K., van Lohuizen, M., Campisi, J., Wazer, D. E., & Band, V. (2002) · PubMed · Cited by 396
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver
Willenbring, H., Bailey, A. S., Foster, M., Akkari, Y., Dorrell, C., Olson, S., Finegold, M., Fleming, W. H., & Grompe, M. (2004) · Nature Medicine · doi:10.1038/nm1062 · Cited by 388 · cited 1×
“Furthermore, most recent studies demonstrated that committed myelomonocytic cells such as macrophages can produce functional epithelial cells by in vivo fusion (47), thus extending the number of cell types that might serve as hypothetically “eligible” fusion partners for tumor cells.”
ResultStem cells and breast cancer: A field in transit
Smalley, M., & Ashworth, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1212 · Cited by 380
Johnson, V. L., Scott, M. I. F., Holt, S. V., Hussein, D., & Taylor, S. S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01006 · Cited by 336 · cited 1×
“Both BUB1 and HEC1 proteins play a key role in the assembly of checkpoint proteins, being required for Mad2 recruitment to the kinetochores (51, 52); this suggests that aberrant BUB1 and HEC1 expression might contribute to and/or reflect the altered function of the mitotic checkpoint in metastatic cancer cells.”
BackgroundSignatures of the Immune Response
Shaffer, A. L., Rosenwald, A., Hurt, E. M., Giltnane, J. M., Lam, L. T., Pickeral, O. K., & Staudt, L. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00194-7 · Cited by 314 · cited 1×
“It has been suggested that sets of coordinately expressed genes defined as cancer-associated gene expression signatures might reflect the cell of origin of cancer (49).”
BackgroundVonlanthen, S., Heighway, J., Altermatt, H. J., Gugger, M., Kappeler, A., Borner, M. M., Lohuizen, M. V., & Betticher, D. C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1791 · Cited by 296 · cited 3×
“BMI-1 expression was previously implicated in human breast and lung cancers (11, 12, 31), which suggests that activation of BMI-1– associated pathway(s) might be relevant to these types of carcinomas as well.”
Backgroundvan Kemenade, F. J., Raaphorst, F. M., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2001) · Blood · doi:10.1182/blood.v97.12.3896 · Cited by 266 · cited 1×
“Altered BMI-1 expression was implicated recently in several nonepithelial malignancies, such as B cell non-Hodgkin lymphoma (35) and pediatric brain tumors (36).”
BackgroundGene expression phenotypic models that predict the activity of oncogenic pathways
Huang, E., Ishida, S., Pittman, J., Dressman, H., Bild, A., Kloos, M., D'Amico, M., Pestell, R. G., West, M., & Nevins, J. R. (2003) · Nature Genetics · doi:10.1038/ng1167 · Cited by 263
Henshall, S. M., Afar, D., Hiller, J., Horvath, L. G., Quinn, D. I., Rasiah, K., Gish, K., Willhite, D., Kench, J. G., Gardiner‐Garden, M., et al. (2003) · PubMed · Cited by 231
In silico dissection of cell-type-associated patterns of gene expression in prostate cancer
Stuart, R. O., Wachsman, W., Berry, C. C., Wang-Rodriguez, J., Wasserman, L., Klacansky, I., Masys, D., Arden, K., Goodison, S., McClelland, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536479100 · Cited by 198
Raaphorst, F. M., Meijer, C. J. L. M., Fieret, E., Blokzijl, T., Mommers, E., Buerger, H., Packeisen, J., Sewalt, R. A. B., Ottet, A. P., & van Diest, P. J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80032-5 · Cited by 194 · cited 2×
“BMI-1 expression was previously implicated in human breast and lung cancers (11, 12, 31), which suggests that activation of BMI-1– associated pathway(s) might be relevant to these types of carcinomas as well.”
BackgroundSTAMEY, T. A., WARRINGTON, J. A., CALDWELL, M. C., CHEN, Z., FAN, Z., MAHADEVAPPA, M., McNEAL, J. E., NOLLEY, R., & ZHANG, Z. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65528-0 · Cited by 192
State-Dependent Decisions Cause Apparent Violations of Rationality in Animal Choice
Schuck-Paim, C., Pompilio, L., & Kacelnik, A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020402 · Cited by 190
Science on the Rise in Developing Countries
Holmgren, M., & Schnitzer, S. A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020001 · Cited by 188
bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.
Haupt, Y., Bath, M. L., Harris, A. W., & Adams, J. M. (1993) · PubMed · Cited by 181
Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma
Gordon, G. J., Jensen, R. V., Hsiao, L.-L., Gullans, S. R., Blumenstock, J. E., Richards, W. G., Jaklitsch, M. T., Sugarbaker, D. J., & Bueno, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.598 · Cited by 177
Brown, A. B., Yang, W., Schmidt, N. O., Carroll, R., Leishear, K. K., Rainov, N. G., Black, P. M., Breakefield, X. O., & Aboody, K. S. (2003) · Human Gene Therapy · doi:10.1089/104303403322611782 · Cited by 163
Stage-Specific Expression of Polycomb Group Genes in Human Bone Marrow Cells
Lessard, J., Baban, S., & Sauvageau, G. (1998) · Blood · doi:10.1182/blood.v91.4.1216 · Cited by 161 · cited 1×
“Bmi-1 oncogene is expressed in all primary myeloid leukemia and leukemic cell lines analyzed so far (1, 8), and overexpression of Bmi-1 causes neoplastic transformation of lymphocytes (9, 10).”
BackgroundGene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis
Luo, J., Dunn, T., Ewing, C., Sauvageot, J., Chen, Y., Trent, J., & Isaacs, W. (2002) · The Prostate · doi:10.1002/pros.10087 · Cited by 138
Alkema, M. J., Jacobs, H., van Lohuizen, M., & Berns, A. J. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201262 · Cited by 118 · cited 1×
“Bmi-1 oncogene is expressed in all primary myeloid leukemia and leukemic cell lines analyzed so far (1, 8), and overexpression of Bmi-1 causes neoplastic transformation of lymphocytes (9, 10).”
BackgroundGene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers
Lancaster, J. M., Dressman, H. K., Whitaker, R. S., Havrilesky, L. J., Gray, J., Marks, J. R., Nevins, J. R., & Berchuck, A. (2003) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2003.07.004 · Cited by 108
Dick, J. E. (2003) · Nature · doi:10.1038/423231a · Cited by 107
Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo
Baron, V. T., Gregorio, G. D., Krones, A., Virolle, T., Calogero, A., Urcis, R., & Mercola, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206560 · Cited by 107 · cited 4×
“These data suggest the presence of a conserved BMI-1–driven pathway, which is similarly engaged in both normal stem cells and a highly malignant subset of human cancers diagnosed in a wide […] Research Article Oncology Find the latest version: http://jci.me/23412-pdf Research article The Journal of Clinical Investigat…”
BackgroundInfluentialGene expression profiling predicts clinical outcome of prostate cancer
Glinsky, G. V., Glinskii, A. B., Stephenson, A. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420032 · Cited by 65
Self-citationGlinsky, G. V., Krones‐Herzig, A., Glinskii, A. B., & Gebauer, G. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10139 · Cited by 26 · cited 10×
“Detailed protocols for data analysis and documentation of the sensitivity, reproducibility, and other aspects of the quantitative statistical microarray analysis using Affymetrix technology have been reported previously (15, 16).”
BackgroundMethodResultInfluentialSelf-citation
Cited by
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
“was associated with a poor prognosis for 10 different types of human malignancies (52).”
BackgroundMolecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
“…of an 11-gene, BMI1-driven stem cell gene signature in a large collection of gene expression data from several different tumor types determined that this signature is a powerful predictor of short diseasefree and overall survival and the risk of distant metastases (Glinsky et al., 2005).”
BackgroundPolycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
Metadata
- Authors
- Glinsky, G. V., Berezovska, O., & Glinskii, A. B.
- Affiliations
- Sidney Kimmel Cancer Center (US)
- Corresponding author
- Glinsky, Gennadi V.
- ORCID
- Glinsky, Gennadi V.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-06-01
- Volume
- 115
- Issue
- 6
- Pages
- 1503-1521
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1136989
- OpenAlex
- W2166666333
- Cited by
- 916
- References
- 68
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 22 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 25 · 2019: 27 · 2018: 38 · 2017: 35 · 2016: 30 · 2015: 50 · 2014: 57 · 2013: 51 · 2012: 60
- FWCI
- 34.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- National Cancer Institute (5R01CA89827, R01CA089827)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- cancer stem cells, BMI1, stem cell self-renewal, gene expression signatures, metastasis, treatment failure, prognosis, distant metastasis, recurrence, epithelial malignancies, hematologic malignancies, multi-cancer analysis
- MeSH terms
- Animals, Female, Humans, Male, Mice, Transgenic, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Nuclear Proteins, Prognosis, Proto-Oncogene Proteins, Repressor Proteins, Biomarkers, Tumor, Neoplastic Stem Cells, Gene Expression Regulation, Neoplastic, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.